Background
Despite differing aetiology and pathology, degenerative retinal diseases including age related macular degeneration (AMD) and retinitis pigmentosa (RP) culminate in photoreceptor cell death. Loss or damage to the retinal pigment epithelium (RPE) is also a common feature of these somewhat disparate conditions. [1, 2] Currently no treatments are known to halt or reverse this cellular loss. Recent advances in gene therapy for degenerative retinal diseases have shown promise in both animal models [3] [4] [5] and clinical trials. [6-8] However, longterm safety and efficacy of gene replacement therapy is yet to be established. In addition the effectiveness of such treatments will be somewhat limited in patients with advanced retinal degeneration, as a result of significant pre-existing cell loss. Thus treatments which aim to replace dystrophic cells are desirable either alone or as an adjunct to gene therapy.
Transplantation and the retina
Positive outcome of cell transplantation studies in animal models, such as the Royal College of Surgeons rat (RCS), have paved the way for human studies. [9-11] Some efficacy has been demonstrated with transplantation of healthy photoreceptors, [12, 13] sheets of foetal neuroretina [14] [15] [16] and donor iris pigment epithelium tissue. [17] [18] [19] In particular transplantation or translocation of RPE cells with or without choroid has shown promise. [20] [21] [22] Autologous RPE transplantation can in principle restore vision, by supporting photoreceptor cell function. However surgical complications remain high and visual improvement so far has been limited. [23, 24] Thus stem cells and/or progenitor cells are being assessed as alternative sources of cells for transplantation.
Stem cell transplantation
Stem cells are typically described as undifferentiated cells which are capable of self-renewal and have the ability to give rise to one or more differentiated cell types. [25] Within the adult eye there are several areas which harbour progenitor cell populations including the ciliary margin of the retina, [26] [27] [28] the iris pigment epithelium [28] [29] [30] and Müller cells. [31] [32] [33] These progenitor cells have been shown to differentiate into a range of neuronal, glial and retinal specific cell types following maintenance in a conducive in vitro environment. It is this obligate requirement for complex cellular interactions and often limited self renewal capacity in vitro which defines these as progenitor cells rather than stem cells. [34] Stem cell therapy to repair and regenerate the corneal epithelium has been successfully employed clinically for a number of years. [35] Retinal cell replacement however remains elusive. To date, a number of studies have investigated various stem cell types as potential sources for retinal transplantation including embryonic stem cells (ESCs), adult stem/progenitor cells and more recently induced pluripotent stem cells (iPS). [36] [37] [38] Results have been encouraging. Following differentiation into retinal pigment epithelium cells in vitro, subretinally transplanted ESCs have led to improvements in visual acuity. [39, 40] In addition, human iPS cells have been differentiated towards functional RPE cells.
This has resulted in short-term survival and maintenance of photoreceptor cells following transplantation into the RCS rat model. [41] Despite these apparently positive findings, efficiency of cell delivery and degree of visual rescue often remain unsatisfactory. This lack of efficacy may be due to a number of reasons for example, RPE cells are anchorage dependent and therefore must quickly (re)attach to an accommodating matrix following transplantation. Bruch's membrane (BM), the inner most layer of the choroid, is the supportive structure upon which RPE cells are normally attached. However, in advanced retinal disease, with age or following macular surgery the basal lamina layer of BM may be damaged or absent. [42] Thus, it is difficult for newly transplanted cells to attach in such a non-permissive environment. Transplanted cells may therefore undergo anoikis, or cells may clump together rather than forming appropriately polarised cell monolayers. Lack of cell to cell contact may also lead to transition of RPE cells to inappropriate phenotypes. [43] Use of stem cells for retinal repair holds enormous promise for generation of sufficient appropriate cell populations for transplantation, due to their proliferative nature and ability to give rise to multiple cell types. The gap between theory and clinical exploitation however remains considerable. [44] Significant challenges remain both from a basic biology and practical application standpoint. Principal among which is identification and use of cell sources which are viable, karyotypically stable and which will yield sufficient cell numbers. [45] The ability to isolate an homogenous, mature population of cells for transplantation is also vitally important to avoid the possibility of teratoma formation, especially when using embryonic derived cell sources. Safe and efficient tissue delivery also needs to be considered, as does survival and integration of the transplanted cells within the host. [28, 46, 47] Any transplanted material must also be capable of maintaining an appropriate state of differentiation in vivo. In addition immune surveillance is a significant issue, thus autologous sources of cells for transplantation, to negate problems with graft rejection, would be the ideal. [48] 
Cell delivery scaffolds
In this review we aim to discuss how substrates can be tailored to enhance retinal cell attachment and viability for transplantation. It has been documented that cells in suspension have a lower immune privilege than those delivered as an intact sheet. [48] Furthermore cells injected as a suspension often fail to regain a fully differentiated phenotype. [49, 50] In addition, the viability of RPE cells delivered to the subretinal space is often dependent on the integrity of the underlying substrate: Bruch's membrane. [51, 52] Thus it may be prudent to transplant sheets of cells rather than suspensions of single cells or cell aggregates. Many techniques and devices are being developed to improve the delivery and survival of transplanted cells, one such being the use of scaffolds for cell attachment and growth prior to transplantation. Natural scaffold materials have been investigated including Descemet's membranes, [53] lens capsules [54, 55] and amniotic membranes. [56, 57] Synthetic polymeric biomaterials have also been utilised as cell delivery vehicles for retinal cell types as detailed in Table 1 .
Biomaterials and the eye
Young and co-workers demonstrated that use of a polymer scaffold for stem cell delivery to the subretinal space presented advantages over simple injection of cell suspensions. [58] .
When a suspension of cells was injected into the eye, problems such as immune response, disorganisation of cells and cell death were encountered. However, when a scaffold made of biodegradable polyester was used, cell survival and organisation were improved. There was also evidence that the scaffold promoted differentiation of the retinal progenitor cells towards mature retinal cell phenotypes. [58] Poly (L-lactic acid) (PLLA) and poly (D,L-lactic-coglycolic acid) (PLGA) were used in this investigation. These polymers were selected as they are biocompatible, easily processable and have been successfully used for tissue engineering applications such as bladder substitution [59] and bone tissue regeneration. [60] The degradation rate of these polymers can also be manipulated by changing properties such as molecular weight and the ratio of lactic to glycolic units. Thus polymers can be designed to degrade over the most appropriate timescale for the desired application.
Aside from PLLA and PLGA, several different polymers and preparation techniques have been investigated in the search for a polymer with suitable biocompatible and mechanical properties to be employed as a cellular scaffold in the eye. Many factors such as surface chemistry, mechanical properties and surface topology can affect the usefulness of different materials for cell attachment and survival. Poly(methyl methacrylate) (PMMA) has been used to manufacture ultra-thin, micro-machined scaffolds for retinal progenitor cells (RPCs). [61] Murine RPCs isolated from enhanced green fluorescent protein positive (GFP+) transgenic mice (C57BL/6 background) were shown to grow and differentiate well on these scaffolds both in vitro and in wild-type C57BL/6 mice. Similarly, poly(glycerol sebacate) (PGS) [62] has been used to manufacture a porous, elastic scaffold and poly(ε-caprolactone) (PCL) [63] to produce ultra-thin nanowire scaffolds. Again, successful growth of murine RPCs was shown both in vitro and wild-type and degenerative mouse models. Both types of scaffold were coated with laminin prior to cell seeding. Laminin is an extracellular matrix (ECM) protein which can aid the survival of transplanted cells by mimicking their natural environment. It was shown that, in culture expression of mature bipolar and photoreceptor cell markers such as rhodopsin, recoverin and PKCα were upregulated on these scaffolds, while several early progenitor markers including Pax6, Hes1, nestin and Sox2 were downregulated. Biodegradable poly(hydroxybutyrate-co-hydroxyvalerate) has been used to manufacture non-porous thin films. [64] These films were modified using an oxygen plasma to generate a more hydrophilic surface. This approach was found to provide a more suitable environment for attachment and growth, of a human RPE cell line, compared to untreated films. Use of an air plasma treatment by Williams et al. was found to increase the surface wettability of commercial poly(urethanes) [65] and poly(dimethylsiloxane) (silicone rubber). [66] These surfaces were found to be well suited to growth of an intact monolayer of RPE cells compared to an untreated surface. Besides synthetic polymers, proteins such as collagen have been manufactured into thin films and shown to be compatible with RPE cells both in vitro and in vivo. [67] However, as the collagen used was derived from equine sources, problems may be encountered at a later stage due to implantation of a non-native protein into the eye.
Surface modification and tissue engineering
The influence of surface modification on biomaterial applications has been extensively studied in other fields of tissue engineering ( Table 1) . The introduction of an amine surface coating, for example, may increase the stability of a biodegradable polymer in the initial stages of degradation. Attempts have been made to use wet chemical and plasma techniques for creating an amine surface layer on PLGA. [68] PLGA has also been treated with ammonia plasma to facilitate collagen attachment for cartilage tissue engineering. [69] A separate study demonstrated that treatment of PGLA with ammonia plasma improves surface roughness thereby providing enhanced attachment of collagen. [70] Poly(urethane) has been surface modified with primary amine groups to facilitate the attachment of ECM molecules producing enhanced murine fibroblast cell attachment and signalling. [71] Nelea et al. [72] were able to show that surface-modifying polypropylene and nylon-6 with ammonia plasma can inhibit expression of type X collagen in human mesenchymal stem cells (MSCs). This has the potential to produce MSCs of the appropriate phenotype for use in intervertebral disc tissue engineering. Carbon dioxide plasma treatments have been used to improve rodent fibroblast and nerve cell adhesion on PLLA surface. [73] While plasma coating of a PLGA surface with titanium oxide has also been shown to improve surface hydrophilicity for human dermal fibroblast cell adhesion. [74] Extracellular matrix (ECM) proteins have natural cell adhesion qualities. A number of researchers have investigated chemical attachment of these proteins to the surface of various synthetic polymers.The effects of adhering the ECM protein laminin to the surface of PLGA by chemical and plasma methods have been investigated. [75] In this study using rodent Schwann cells, laminin coating was shown to significantly improve cell attachment and affinity for directing peripheral nerve regeneration. Another approach has been to attach collagen to polyester surfaces to increase human articular chondrocyte cell attachment. [76] There is some evidence, however, that treatment of poly(ε-caprolactone) (PCL) with an air plasma is more effective at improving proliferation of Schwann cells than PCL-collagen scaffolds. [ by Britland et al. [93] suggest that both types of cues may act synergistically. Thus biomaterials need to be engineered to mimic these natural membranes as closely as possible. [94] The influence of surface topology on cellular growth has been reviewed previously. [95] Studies have also been conducted to assess how material topography can be used to build 3D tissue structures including corneal stroma. [96] This approach was found to increase the functionality of tissue-engineered cellular sheets.
The mechanical properties of substrates also have an important role to play in creating an appropriate tissue engineering scaffold for cellular attachment and proliferation. Mechanical stiffness of materials has been shown to influence the differentiation of neural stem cells. [97] These properties are also important when considering the method of implanting biomaterials into the body. 
